Akcea Therapeutics Ireland Limited informs healthcare professionals about the permanent discontinuation of the medicinal product TEGSEDI (Inotersen sodium, 284 mg solution for injection in pre-filled syringe), in the European Union (EU) from 1 December 2026 onwards.
To read the letter, click here.
